Premium
Mucinous eccrine carcinoma of the eyelid
Author(s) -
Snow Stephen N.,
Reizner George T.
Publication year - 1992
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19921015)70:8<2099::aid-cncr2820700815>3.0.co;2-c
Subject(s) - medicine , eyelid , scalp , mucinous carcinoma , head and neck , carcinoma , primary tumor , distant metastasis , surgery , dermatology , cancer , metastasis , pathology , adenocarcinoma
Background . Mucinous eccrine carcinoma (MEC) is a rare malignant tumor that typically arises in the periorbital area. Methods . The authors report the 73rd case of primary MEC of the skin. This patient's clinicopathologic findings and the world literature are reviewed. Results . Patient ages range from 8‐84 years (median, 63 years). The male‐to‐female ratio was approximately 2:1. The racial distribution was 67% white, 32% black, and 4% Asian. Primary MEC originates in the head and neck region in approximately 75% of patients. The most common location was the periorbital area (40% or 29 of 73 patients). The local recurrence rate after conventional surgery was: eyelid, 34%; scalp, 36%; and face, 33%. Conclusions . Primary MEC is often a slow‐growing tumor that may recur after traditional surgical excision. Recurrent eyelid MEC tends to be locally destructive with a regional metastatic rate of 3.5% (1 of 29). The regional metastatic rate for all sites was 11%, and the distant metastatic rate was 3%.